Back to top

Image: Bigstock

Waters Corporation

Read MoreHide Full Article

Waters Corp. has a robust earnings surprise history, having consistently beaten estimates in each of the four trailing quarters. Encouragingly, estimates have moved north ahead of the company’s second quarter earnings release. Factors including robust operational performance across pharmaceutical end markets, coupled with striking growth in recurring-revenue products are proving to be major tailwinds for the company’s growth. The company’s leading position in the high-performance liquid chromatography and mass spectrometry markets will likely continue to be a strong revenue driver. Waters Corp. continues to see modest growth in demand for its bench top LC and LC-MS instruments, which are used in broad-based life science applications. Yet, adverse currency translations continue to affect its overall sales, and mounting debts remain a major concern.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Waters Corporation (WAT) - free report >>

Published in